These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

455 related articles for article (PubMed ID: 8992979)

  • 1. Differential effects of IL-12 receptor blockade with IL-12 p40 homodimer on the induction of CD4+ and CD8+ IFN-gamma-producing cells.
    Piccotti JR; Chan SY; Li K; Eichwald EJ; Bishop DK
    J Immunol; 1997 Jan; 158(2):643-8. PubMed ID: 8992979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alloantigen-reactive Th1 development in IL-12-deficient mice.
    Piccotti JR; Li K; Chan SY; Ferrante J; Magram J; Eichwald EJ; Bishop DK
    J Immunol; 1998 Feb; 160(3):1132-8. PubMed ID: 9570526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IL-12 antagonism induces T helper 2 responses, yet exacerbates cardiac allograft rejection. Evidence against a dominant protective role for T helper 2 cytokines in alloimmunity.
    Piccotti JR; Chan SY; Goodman RE; Magram J; Eichwald EJ; Bishop DK
    J Immunol; 1996 Sep; 157(5):1951-7. PubMed ID: 8757314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diversion of CD4+ T cell development from regulatory T helper to effector T helper cells alters the contact hypersensitivity response.
    DiIulio NA; Xu H; Fairchild RL
    Eur J Immunol; 1996 Nov; 26(11):2606-12. PubMed ID: 8921946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Th1 development of naive CD4+ T cells is inhibited by co-activation with anti-CD4 monoclonal antibodies.
    Goedert S; Germann T; Hoehn P; Koelsch S; Palm N; Rüde E; Schmitt E
    J Immunol; 1996 Jul; 157(2):566-73. PubMed ID: 8752903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of CD8+ effector T cells is differentially regulated by IL-18 and IL-12.
    Okamoto I; Kohno K; Tanimoto T; Ikegami H; Kurimoto M
    J Immunol; 1999 Mar; 162(6):3202-11. PubMed ID: 10092771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of Th1 and Th2 cytokines expressing CD4+ and CD8+ T cells in rheumatoid arthritis by flow cytometry.
    Berner B; Akça D; Jung T; Muller GA; Reuss-Borst MA
    J Rheumatol; 2000 May; 27(5):1128-35. PubMed ID: 10813277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Type 2 immune deviation has differential effects on alloreactive CD4+ and CD8+ T cells.
    Matesic D; Valujskikh A; Pearlman E; Higgins AW; Gilliam AC; Heeger PS
    J Immunol; 1998 Nov; 161(10):5236-44. PubMed ID: 9820495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IL-12 up-regulates IL-18 receptor expression on T cells, Th1 cells, and B cells: synergism with IL-18 for IFN-gamma production.
    Yoshimoto T; Takeda K; Tanaka T; Ohkusu K; Kashiwamura S; Okamura H; Akira S; Nakanishi K
    J Immunol; 1998 Oct; 161(7):3400-7. PubMed ID: 9759857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Limiting dilution analysis of CD4 T-cell cytokine production in mice administered native versus polymerized ovalbumin: directed induction of T-helper type-1-like activation.
    Gieni RS; Yang X; Kelso A; Hayglass KT
    Immunology; 1996 Jan; 87(1):119-26. PubMed ID: 8666423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The interleukin-12 subunit p40 specifically inhibits effects of the interleukin-12 heterodimer.
    Mattner F; Fischer S; Guckes S; Jin S; Kaulen H; Schmitt E; Rüde E; Germann T
    Eur J Immunol; 1993 Sep; 23(9):2202-8. PubMed ID: 8103745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential capacities of CD4+, CD8+, and CD4-CD8- T cell subsets to express IL-18 receptor and produce IFN-gamma in response to IL-18.
    Tomura M; Maruo S; Mu J; Zhou XY; Ahn HJ; Hamaoka T; Okamura H; Nakanishi K; Clark S; Kurimoto M; Fujiwara H
    J Immunol; 1998 Apr; 160(8):3759-65. PubMed ID: 9558078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo depletion of CD8+ T cells results in Th2 cytokine production and alternate mechanisms of allograft rejection.
    Chan SY; DeBruyne LA; Goodman RE; Eichwald EJ; Bishop DK
    Transplantation; 1995 Apr; 59(8):1155-61. PubMed ID: 7732563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential effects of interleukin-12 on the development of naive mouse CD4+ T cells.
    Schmitt E; Hoehn P; Germann T; Rüde E
    Eur J Immunol; 1994 Feb; 24(2):343-7. PubMed ID: 7905416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synergistic effects of IL-7 and IL-12 on human T cell activation.
    Mehrotra PT; Grant AJ; Siegel JP
    J Immunol; 1995 May; 154(10):5093-102. PubMed ID: 7730615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polarization of IL-4- and IFN-gamma-producing CD4+ T cells following activation of naive CD4+ T cells.
    Nakamura T; Kamogawa Y; Bottomly K; Flavell RA
    J Immunol; 1997 Feb; 158(3):1085-94. PubMed ID: 9013946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IL-12 is essential for resistance against Yersinia enterocolitica by triggering IFN-gamma production in NK cells and CD4+ T cells.
    Bohn E; Autenrieth IB
    J Immunol; 1996 Feb; 156(4):1458-68. PubMed ID: 8568248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-1 alpha and TNF-alpha are required for IL-12-induced development of Th1 cells producing high levels of IFN-gamma in BALB/c but not C57BL/6 mice.
    Shibuya K; Robinson D; Zonin F; Hartley SB; Macatonia SE; Somoza C; Hunter CA; Murphy KM; O'Garra A
    J Immunol; 1998 Feb; 160(4):1708-16. PubMed ID: 9469428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IFN-gamma-inducing factor (IGIF) is a costimulatory factor on the activation of Th1 but not Th2 cells and exerts its effect independently of IL-12.
    Kohno K; Kataoka J; Ohtsuki T; Suemoto Y; Okamoto I; Usui M; Ikeda M; Kurimoto M
    J Immunol; 1997 Feb; 158(4):1541-50. PubMed ID: 9029088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AsialoGM1+CD8+ central memory-type T cells in unimmunized mice as novel immunomodulator of IFN-gamma-dependent type 1 immunity.
    Kosaka A; Wakita D; Matsubara N; Togashi Y; Nishimura S; Kitamura H; Nishimura T
    Int Immunol; 2007 Mar; 19(3):249-56. PubMed ID: 17229818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.